Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.
about
Subthalamic nucleus deep brain stimulation impacts language in early Parkinson's disease.Subthalamic nucleus deep brain stimulation in elderly patients--analysis of outcome and complications.Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleusCognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's diseaseEffects of STN DBS on memory guided force control in Parkinson's disease (June 2007)Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease.Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based reviewApomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management.What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?High frequency deep brain stimulation of the subthalamic nucleus versus continuous subcutaneous apomorphine infusion therapy: a review.Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease.Apomorphine and levodopa infusion therapies for advanced Parkinson's disease.The role of subcutaneous infusion of apomorphine in Parkinson's disease.Clinical insights into use of apomorphine in Parkinson's disease: tools for clinicians.Advances in dopamine receptor agonists for the treatment of Parkinson's disease.l-Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior.Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease.
P2860
Q30464816-55057A0E-7F80-4B29-A59C-3398AA0994B4Q33279179-F14CF719-B040-4B66-8FF5-00E166610C70Q35614156-06577760-224C-4044-A0C2-26C14A34D65DQ36142302-C2AE4945-B01E-438C-9790-2E50BD71C7F9Q36226947-2A364980-A1B1-4ABD-AF00-9FFF439AD847Q36614660-85007A33-EB5F-47D8-B028-1E089FDFBFD8Q36930926-49F9E187-C769-4478-A10E-92FAD7CEF58BQ37302240-54FBE3D6-D022-4BD4-9A4D-ABBC70DACD78Q37507973-9084313F-DFF2-43E8-8BD5-7367F156E115Q37824279-2EC7EB56-0EE7-4DF7-807D-D78BEC81A922Q37824441-17BE0000-AF4C-4F73-B180-0F44448D3D29Q38155589-EBEA9AC2-45B6-4254-9F06-FE97B542D6CFQ38215506-81DF1E10-E57C-4A05-855D-79C325059FEBQ38219351-7B29D6A4-FD54-4A4E-BB73-9BB9503FF5C7Q38237228-E8A29963-232F-4DB2-8288-BEAA99E28C3DQ38937096-B07F82CA-C11F-43D0-9E7A-ED62D0923ECEQ47140289-63B325B5-80F2-4567-A354-CA91BD947CD9Q47868277-FC837AB5-6969-46C7-A2A5-07FFE48521F0Q47891722-3070E09F-F613-4D6D-8C17-219FD71CEB07
P2860
Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Comparative cognitive effects ...... rphine in Parkinson's disease.
@en
Comparative cognitive effects ...... rphine in Parkinson's disease.
@nl
type
label
Comparative cognitive effects ...... rphine in Parkinson's disease.
@en
Comparative cognitive effects ...... rphine in Parkinson's disease.
@nl
prefLabel
Comparative cognitive effects ...... rphine in Parkinson's disease.
@en
Comparative cognitive effects ...... rphine in Parkinson's disease.
@nl
P2093
P2860
P356
P1433
P1476
Comparative cognitive effects ...... rphine in Parkinson's disease.
@en
P2093
Carme Junqué
Jordi Rumià
MaJosé Martí
Manuela Pilleri
Montse Alegret
P2860
P304
P356
10.1002/MDS.20237
P407
P577
2004-12-01T00:00:00Z